0

    524663

    BIBCL

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    BHARAT IMMUNOLOGICALS & BIOLOG Share Price Today

    Investment Returns

    Over 1 Month -8.11% Over 3 Months -10.67% Over 6 Months -16.98% Over 1 Year -30.94%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    BHARAT IMMUNOLOGICALS & BIOLOG fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 68.30
    • P/E Ratio (TTM) -3.68
    • Beta 0.74
    • Book Value / share -7.53
    • Return on equity 0.00%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -4.92
    info icon alternate text

    BHARAT IMMUNOLOGICALS & BIOLOG Financials

    Open financial information
    Revenue
    Net income
    Particulars SEP 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 6.81
    Net Profit -4.92
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -1.14
    EBITDA -4.53
    Effective Tax Rate (%) 26.01
    Particulars JUN 2023 (Values in Cr)
    Revenue 0.00
    Operating Expense 6.06
    Net Profit -4.59
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -1.06
    EBITDA -4.22
    Effective Tax Rate (%) 23.11
    Particulars MAR 2023 (Values in Cr)
    Revenue 7.65
    Operating Expense 13.82
    Net Profit -3.88
    Net Profit Margin (%) -50.71
    Earnings Per Share (EPS) -0.90
    EBITDA -3.53
    Effective Tax Rate (%) 31.69
    Particulars DEC 2022 (Values in Cr)
    Revenue 0.00
    Operating Expense 6.43
    Net Profit -4.68
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) -1.08
    EBITDA -4.62
    Effective Tax Rate (%) 26.06
    Particulars SEP 2022 (Values in Cr)
    Revenue 26.48
    Operating Expense 30.75
    Net Profit -3.08
    Net Profit Margin (%) -11.63
    Earnings Per Share (EPS) -0.71
    EBITDA -2.17
    Effective Tax Rate (%) 22.22
    Particulars MAR 2023 (Values in Cr)
    Revenue 44.61
    Operating Expense 67.94
    Net Profit -16.64
    Net Profit Margin (%) -37.30
    Earnings Per Share (EPS) -3.85
    EBITDA -15.02
    Effective Tax Rate (%) 25.28
    Particulars MAR 2022 (Values in Cr)
    Revenue 78.39
    Operating Expense 89.18
    Net Profit -8.75
    Net Profit Margin (%) -11.16
    Earnings Per Share (EPS) -2.03
    EBITDA -3.88
    Effective Tax Rate (%) 9.59
    Particulars MAR 2021 (Values in Cr)
    Revenue 85.33
    Operating Expense 111.22
    Net Profit -18.11
    Net Profit Margin (%) -21.22
    Earnings Per Share (EPS) 1.10
    EBITDA -19.19
    Effective Tax Rate (%) 25.19
    Particulars MAR 2020 (Values in Cr)
    Revenue 66.84
    Operating Expense 82.22
    Net Profit -10.21
    Net Profit Margin (%) -15.27
    Earnings Per Share (EPS) -2.36
    EBITDA -9.21
    Effective Tax Rate (%) 28.09
    Particulars MAR 2019 (Values in Cr)
    Revenue 83.65
    Operating Expense 95.24
    Net Profit -5.79
    Net Profit Margin (%) -6.92
    Earnings Per Share (EPS) -1.57
    EBITDA -5.09
    Effective Tax Rate (%) 21.43
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share -5.43
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -35.10
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share -1.48
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.00
    EBITDA Margin -4.94
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 0.55
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 1.33
    EBITDA Margin -22.48
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 4.74
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.69
    EBITDA Margin -13.79
    Particulars MAR 2019 (Values in Cr)
    Book Value / Share 7.10
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.47
    EBITDA Margin -6.10
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 8.73
    Total Assets 185.66
    Total Liabilities 185.66
    Total Equity 87.79
    Share Outstanding 4
    Price to Book Ratio -4.09
    Return on Assets (%) -9.18
    Return on Capital (%) -10.79
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 13.00
    Total Assets 212.72
    Total Liabilities 212.72
    Total Equity 105.35
    Share Outstanding 4
    Price to Book Ratio -18.99
    Return on Assets (%) -4.11
    Return on Capital (%) -4.78
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 10.53
    Total Assets 103.98
    Total Liabilities 103.98
    Total Equity 34.04
    Share Outstanding 4
    Price to Book Ratio 82.73
    Return on Assets (%) -17.41
    Return on Capital (%) -29.53
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 12.09
    Total Assets 126.82
    Total Liabilities 126.82
    Total Equity 20.47
    Share Outstanding 4
    Price to Book Ratio 1.23
    Return on Assets (%) -8.05
    Return on Capital (%) -43.43
    Particulars MAR 2019 (Values in Cr)
    Cash & Short Term Investments 7.93
    Total Assets 124.96
    Total Liabilities 124.96
    Total Equity 30.67
    Share Outstanding 4
    Price to Book Ratio 1.08
    Return on Assets (%) -4.63
    Return on Capital (%) -9.21
    Particulars MAR 2023 (Values in Cr)
    Net Income -22.85
    Cash from Operations 10.88
    Cash from Investing 0.46
    Cash from Financing -14.70
    Net change in Cash -3.35
    Free Cash Flow 10.88
    Particulars MAR 2022 (Values in Cr)
    Net Income -9.68
    Cash from Operations -42.11
    Cash from Investing 0.53
    Cash from Financing 45.00
    Net change in Cash 3.41
    Free Cash Flow -42.11
    Particulars MAR 2021 (Values in Cr)
    Net Income -24.20
    Cash from Operations 11.77
    Cash from Investing 0.66
    Cash from Financing -12.20
    Net change in Cash 0.24
    Free Cash Flow 11.77
    Particulars MAR 2020 (Values in Cr)
    Net Income -14.20
    Cash from Operations 34.07
    Cash from Investing 0.91
    Cash from Financing -34.41
    Net change in Cash 0.57
    Free Cash Flow 34.07
    Particulars MAR 2019 (Values in Cr)
    Net Income -7.37
    Cash from Operations -32.09
    Cash from Investing 0.69
    Cash from Financing 30.70
    Net change in Cash -0.69
    Free Cash Flow -32.07
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 14.47 1.68 267.22 23.12 38.85
    BLISS GVS PHARMA LTD. 467.40 37.63 4.16 4965.84 118.35 552.90
    CIPLA LTD 1472.95 33.25 3.45 118991.58 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 501.25 23.44 3.62 1475.23 256.40 507.20
    GLAXOSMITHKLINE PHARMACEUTICAL 2653.45 46.72 19.82 44951.04 2088.00 3202.80
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 34.87 24.38 4.49 267.22 23.12 38.85
    AMRUTAJAN HEALTH LTD 515.00 23.08 4.02 1488.90 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8103.65 105.90 23.21 20259.13 7630.00 9850.00
    BLISS GVS PHARMA LTD. 467.40 50.58 4.29 4965.84 118.35 552.90

    BHARAT IMMUNOLOGICALS & BIOLOG shareholding pattern

    Holding
    40.74%
    59.25%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    BHARAT IMMUNOLOGICALS & BIOLOG Technicals Summary

    15.82 2.72 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 15.60
    • 26 Days 16.40
    • 10 Days 15.90
    • 50 Days 16.80
    • 12 Days 16.00
    • 100 Days 17.30
    • 20 Days 16.30
    • 200 Days 18.40
    15.40 PIVOT
    First Support 15.25 First Resistance 15.55 Second Support 15.10 Second Resistance 15.70 Third Support 14.95 Third Resistance 15.85
    RSI 26.54 ADX 19.14 MACD -0.44 Williams % R -92.50 Commodity Channel Index (CCI) -147.31
    Date 2026-07-31 Week 18734.00 Same Day 17342.00 Month 15277.00
    1 Year 0.74 3 Year 0.81
    Over 1 Month
    -8.11% down
    Over 1 Year
    -30.94% down
    Over 3 Months
    -10.67% down
    Over 3 Years
    -10.73% down
    Over 6 Months
    -16.98% down
    Over 5 Years
    -23.91% down

    BHARAT IMMUNOLOGICALS & BIOLOG Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Bharat Immunological & Biological Corporation Ltd?

    Answer Field

    Bharat Immunological & Biological Corporation Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 15.82 as on Aug 03 2026 02:52 PM.

    What is the Market Cap of Bharat Immunological & Biological Corporation Ltd Share?

    Answer Field

    The market cap of Bharat Immunological & Biological Corporation Ltd for NSE ₹ 0.00 & for BSE ₹ 68.30 as on Aug 03 2026 02:52 PM.

    What is the 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd?

    Answer Field

    The 52 Week High and Low of Bharat Immunological & Biological Corporation Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 23.19 and ₹ 14.10.

    What is 1 year return for Bharat Immunological & Biological Corporation Ltd?

    Answer Field

    The 1 year returns on the stock has been -30.94%.

    What is the P/E Ratio of Bharat Immunological & Biological Corporation Ltd Share?

    Answer Field

    As on Aug 03 2026 02:52 PM the price-to-earnings (PE) ratio for Bharat Immunological & Biological Corporation Ltd share is -3.68.

    What is the PB ratio of Bharat Immunological & Biological Corporation Ltd Share?

    Answer Field

    As on Aug 03 2026 02:52 PM, the price-to-book (PB) ratio for Bharat Immunological & Biological Corporation Ltd share is -7.53.

    How to Buy Bharat Immunological & Biological Corporation Ltd Share?

    Answer Field

    You can trade in Bharat Immunological & Biological Corporation Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Bharat Immunological & Biological Corporation Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Bharat Immunological & Biological Corporation Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Bharat Immunological & Biological Corporation Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |